Compatibility Studies of Different Crystal Forms of Imatinib Mesylate with Pharmaceutical Excipients.

Mou Y, Zhao Y, Wen S, Li X, Zhang W, Xu X, Wang Y

Open source

DOI: 10.1021/acsomega.4c07188
Published: 2025 Feb 18
Container: ACS omega
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1021/acsomega.4c07188,
  title = {Compatibility Studies of Different Crystal Forms of Imatinib Mesylate with Pharmaceutical Excipients.},
  author = {Mou Y and Zhao Y and Wen S and Li X and Zhang W and Xu X and Wang Y},
  year = {2025},
  journal = {ACS omega},
  doi = {10.1021/acsomega.4c07188},
  url = {https://doi.org/10.1021/acsomega.4c07188}
}

RIS

TY  - JOUR
TI  - Compatibility Studies of Different Crystal Forms of Imatinib Mesylate with Pharmaceutical Excipients.
AU  - Mou Y
AU  - Zhao Y
AU  - Wen S
AU  - Li X
AU  - Zhang W
AU  - Xu X
AU  - Wang Y
PY  - 2025
JO  - ACS omega
DO  - 10.1021/acsomega.4c07188
UR  - https://doi.org/10.1021/acsomega.4c07188
ER  -

APA

Y, M., Y, Z., S, W., X, L., W, Z., X, X., & Y, W. (2025). Compatibility Studies of Different Crystal Forms of Imatinib Mesylate with Pharmaceutical Excipients.. ACS omega. https://doi.org/10.1021/acsomega.4c07188

Source records

pubmed · retrieved 2026-11-10T14:58:47.944Z
europe-pmc · retrieved 2026-11-10T14:58:47.959Z
doaj · retrieved 2026-11-10T14:58:47.957Z